miR-29c contribute to glioma cells temozolomide sensitivity by targeting O(6)-methylguanine-DNA methyltransferases indirectly

Temozolomide (TMZ) is the most commonly used alkylating agent in glioma chemotherapy. However growing resistance to TMZ remains a major challenge to clinicians. The DNA repair protein O(6)-methylguanine-DNA methytransferase (MGMT) plays critical roles in TMZ resistance. Promoter methylation can inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Songhua, Yang, Zhen, Qiu, Xingsheng, Lv, Ruiyan, Liu, Jun, Wu, Ming, Liao, Yiwei, Liu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226579/
https://www.ncbi.nlm.nih.gov/pubmed/27384876
http://dx.doi.org/10.18632/oncotarget.10357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226579/
https://www.ncbi.nlm.nih.gov/pubmed/27384876
http://dx.doi.org/10.18632/oncotarget.10357

Ejemplares similares